TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Select Medical ( (SEM) ) has issued an update.
On July 30, 2025, Select Medical Holdings Corporation’s Board of Directors approved amendments to the company’s bylaws. These changes enhance procedural and disclosure requirements for stockholder nominations and proposals at meetings, aligning with SEC’s universal proxy rules. The amendments require stockholders to provide a proxy statement and evidence of soliciting proxies from holders of at least 67% of the voting power for director elections, impacting the company’s governance and stakeholder engagement.
The most recent analyst rating on (SEM) stock is a Buy with a $25.00 price target. To see the full list of analyst forecasts on Select Medical stock, see the SEM Stock Forecast page.
Spark’s Take on SEM Stock
According to Spark, TipRanks’ AI Analyst, SEM is a Outperform.
Select Medical’s overall score is driven by solid earnings call results and strategic corporate events, countered by technical analysis indicating bearish momentum. Financial performance shows stability, albeit with leverage concerns.
To see Spark’s full report on SEM stock, click here.
More about Select Medical
Average Trading Volume: 1,297,734
Technical Sentiment Signal: Sell
Current Market Cap: $1.56B
For detailed information about SEM stock, go to TipRanks’ Stock Analysis page.